FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection, USP 10mg per 5mL Due to Mislabeling
Food & Beverages
Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Unleashing the Power of FDA Data to Support COVID-19 Vaccine Distribution to Food and Agriculture Workers
FDA's 21 FORWARD Tool Supports COVID-19 Vaccine Distribution to Food and Agriculture Workers
Accelerating the Adoption of Advanced Manufacturing Technologies to Strengthen Our Public Health Infrastructure
FDA and industry have to accelerate the adoption of advanced manufacturing technologies to strengthen the nation’s public health infrastructure.
Pandemic Response, Pandemic Preparation
Pandemic Recovery and Preparedness Plan initiative strengthens on-going COVID-19 pandemic response and our resiliency for future public health emergencies.
Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency
Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency (COVID-19)
Animal & Veterinary, Biologics, Drugs